Unethical studies of ivermectin for covid-19.
Publication
, Journal Article
Meyerowitz-Katz, G; Wieten, S; Medina Arellano, MDJ; Yamey, G
Published in: BMJ (Clinical research ed.)
April 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
BMJ (Clinical research ed.)
DOI
EISSN
1756-1833
ISSN
0959-8138
Publication Date
April 2022
Volume
377
Start / End Page
o917
Related Subject Headings
- Treatment Outcome
- SARS-CoV-2
- Ivermectin
- Humans
- General & Internal Medicine
- COVID-19
- Antiviral Agents
- Antiparasitic Agents
- 52 Psychology
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Meyerowitz-Katz, G., Wieten, S., Medina Arellano, M. D. J., & Yamey, G. (2022). Unethical studies of ivermectin for covid-19. BMJ (Clinical Research Ed.), 377, o917. https://doi.org/10.1136/bmj.o917
Meyerowitz-Katz, Gideon, Sarah Wieten, María de Jesús Medina Arellano, and Gavin Yamey. “Unethical studies of ivermectin for covid-19.” BMJ (Clinical Research Ed.) 377 (April 2022): o917. https://doi.org/10.1136/bmj.o917.
Meyerowitz-Katz G, Wieten S, Medina Arellano MDJ, Yamey G. Unethical studies of ivermectin for covid-19. BMJ (Clinical research ed). 2022 Apr;377:o917.
Meyerowitz-Katz, Gideon, et al. “Unethical studies of ivermectin for covid-19.” BMJ (Clinical Research Ed.), vol. 377, Apr. 2022, p. o917. Epmc, doi:10.1136/bmj.o917.
Meyerowitz-Katz G, Wieten S, Medina Arellano MDJ, Yamey G. Unethical studies of ivermectin for covid-19. BMJ (Clinical research ed). 2022 Apr;377:o917.
Published In
BMJ (Clinical research ed.)
DOI
EISSN
1756-1833
ISSN
0959-8138
Publication Date
April 2022
Volume
377
Start / End Page
o917
Related Subject Headings
- Treatment Outcome
- SARS-CoV-2
- Ivermectin
- Humans
- General & Internal Medicine
- COVID-19
- Antiviral Agents
- Antiparasitic Agents
- 52 Psychology
- 42 Health sciences